This study evaluates the diagnostic and prognostic value of serum (sNfL) and cerebrospinal fluid neurofilament light chain (cNfL) levels in amyotrophic lateral sclerosis (ALS) patients. The gene discussed is NEFL; the disease is amyotrophic lateral sclerosis.